Skip to main content
main-content

Medicine Matters rheumatology

26-06-2018 | Rheumatoid arthritis | EULAR 2018 | Video

Expert commentary: Trial results on upadacitinib for the treatment of RA

Roy Fleischmann comments on the results of the SELECT-MONOTHERAPY and SELECT-NEXT trials, which provide further evidence for the benefits of upadacitinib in patients with RA (6:18).

Read the accompanying news story

19-06-2018 | Psoriatic arthritis | EULAR 2018 | Video

Expert commentary: Low rates of radiographic progression with secukinumab treatment in PsA patients

Douglas Veale comments on study results showing that secukinumab-treated PsA patients have low rates of radiographic progression regardless of prior TNF inhibitor exposure or concomitant methotrexate treatment (2:45).

Read the accompanying news story

18-06-2018 | Rheumatoid arthritis | EULAR 2018 | Video

Expert commentary: Malignancy and infection risk with JAK inhibitors in RA patients

EULAR president Hans Bijlsma comments on a meta-analysis evaluating the risk for malignancy or serious infection among RA patients treated with JAK inhibitors (5:44).

Read the accompanying news story

15-06-2018 | Rheumatoid arthritis | EULAR 2018 | Video

Researcher comment: MRI monitoring may not be justified in RA patients in clinical remission

Signe Møller-Bisgaard discusses her findings from the IMAGINE-RA study looking at the effects of adding the target of no osteitis or bone marrow edema on MRI to a conventional treat-to-target regimen in patients with RA (5:10).

Read the accompanying news story

15-06-2018 | Systemic lupus erythematosus | EULAR 2018 | Video

Expert commentary: Promising results with herpes zoster vaccine in SLE patients

Thomas Dörner comments on study results demonstrating that a live attenuated herpes zoster vaccine is well tolerated and provokes an antibody response in patients with SLE (5:14).

Read the accompanying news story here

14-06-2018 | TNF inhibitors | EULAR 2018 | Video

Researcher comment: Role of TNF inhibitors on need for joint replacement in RA

​​​​​​​Samuel Hawley comments on his research findings showing that TNF inhibitors might not play as big a role in the recent reduction in joint replacement procedures in patients with RA as originally thought and that additional factors are likely to be involved. (2:59)

Read the related news story

14-06-2018 | Rheumatoid arthritis | EULAR 2018 | Video

Expert commentary: COBRA trial 23-year follow-up analysis on mortality rates

Elena Nikiphorou provides her thoughts on the findings of this trial showing a normalization of mortality in patients with rheumatoid arthritis receiving early, intensive treatment (2:41).

Read the accompanying news story here.

Image Credits